{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:15:33Z","timestamp":1791656133120,"version":"4.3.4"},"reference-count":21,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["SAGE Open Medicine"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To investigate pregnant women\u2019s attitudes and behaviours towards hypertensive disorders of pregnancy and their treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Face-to-face, in-depth interviews were undertaken with 27 pregnant women diagnosed with and being treated for hypertensive disorders of pregnancy to investigate attitudes and behaviours regarding the conditions and their treatment. Written consent was obtained individually from each participant, and the interviews ranged from 16 to 54\u2009minutes. Data collection was continued until thematic saturation was reached. Thematic analysis was employed to interpret the data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Four major themes emerged around beliefs and behaviours of pregnant women regarding treatment of their hypertension: understanding of hypertensive disorders of pregnancy and their implications, risks versus benefits of antihypertensive medication during pregnancy, trust in medical professionals and adherence to medication. The women\u2019s level of understanding of hypertensive disorders of pregnancy and their implications determined whether they were able to make informed decisions about their treatment. Prior experiences and concern for preservation of the pregnancy played major roles in the perception of the risk\/benefit balance of using antihypertensive medication during pregnancy. The degree of trust in the treating medical professionals varied according to the perception of their confidence and knowledge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Sound understanding of the condition, a positive risk\/benefit balance regarding antihypertensive medication use during pregnancy, and trust in medical professionals contributed to adherence to medication. Good communication with healthcare professionals is important to achieve optimal treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20503121211032480","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T03:02:18Z","timestamp":1626318138000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":11,"title":["\u2018I wish my body was stronger\u2019: A qualitative study of attitudes and behaviours regarding treatment of hypertensive disorders of pregnancy"],"prefix":"10.1177","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4162-0711","authenticated-orcid":false,"given":"Amyna","family":"Helou","sequence":"first","affiliation":[{"name":"Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Stewart","sequence":"additional","affiliation":[{"name":"Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kath","family":"Ryan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, University of Reading, Reading, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0326-0495","authenticated-orcid":false,"given":"Johnson","family":"George","sequence":"additional","affiliation":[{"name":"Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"bibr1-20503121211032480","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12399"},{"key":"bibr2-20503121211032480","unstructured":"World Health Organisation. The World Health Report 2005: Make every mother and child count. 2005, https:\/\/www.who.int\/whr\/2005\/en\/ (accessed 6 November 2020)."},{"key":"bibr3-20503121211032480","doi-asserted-by":"publisher","DOI":"10.1080\/02646830701691384"},{"key":"bibr4-20503121211032480","doi-asserted-by":"publisher","DOI":"10.3109\/10641955.2010.507851"},{"key":"bibr5-20503121211032480","doi-asserted-by":"publisher","DOI":"10.1016\/j.midw.2017.01.004"},{"key":"bibr6-20503121211032480","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229622"},{"key":"bibr7-20503121211032480","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0744-2"},{"key":"bibr8-20503121211032480","doi-asserted-by":"publisher","DOI":"10.3109\/02770903.2012.678024"},{"key":"bibr9-20503121211032480","unstructured":"Sabate E (ed.) Adherence to long-term therapies: evidence for action. Geneva: World Health Organization, https:\/\/www.who.int\/chp\/knowledge\/publications\/adherence_full_report.pdf (accessed 20 September 2020)."},{"key":"bibr10-20503121211032480","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313220"},{"key":"bibr11-20503121211032480","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.12499"},{"key":"bibr12-20503121211032480","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2011.01312.x"},{"key":"bibr13-20503121211032480","unstructured":"Microsoft Windows NVivo 10, http:\/\/help-nv10.qsrinternational.com\/desktop\/concepts\/about_nodes.htm (accessed 21 February 2020)."},{"key":"bibr14-20503121211032480","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"bibr15-20503121211032480","unstructured":"NPS Medicine Wise. Presolol (Labetalol) Consumer Medicines Information leaflet (CMI), https:\/\/www.nps.org.au\/medicine-finder\/presolol-tablets (accessed 15 August 2020)."},{"key":"bibr16-20503121211032480","unstructured":"The Royal Womens Hospital. Explaining Preeclampsia 2018, https:\/\/thewomens.r.worldssl.net\/images\/uploads\/fact-sheets\/Preeclampsia-2018.pdf (accessed 14 July 2020)."},{"key":"bibr17-20503121211032480","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-019-00937-w"},{"key":"bibr18-20503121211032480","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt193"},{"key":"bibr19-20503121211032480","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e31827da5b9"},{"key":"bibr20-20503121211032480","doi-asserted-by":"publisher","DOI":"10.1007\/s10995-017-2370-4"},{"key":"bibr21-20503121211032480","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2018.7585"}],"container-title":["SAGE Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20503121211032480","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20503121211032480","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20503121211032480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:19:46Z","timestamp":1777594786000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20503121211032480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":21,"alternative-id":["10.1177\/20503121211032480"],"URL":"https:\/\/doi.org\/10.1177\/20503121211032480","relation":{},"ISSN":["2050-3121","2050-3121"],"issn-type":[{"value":"2050-3121","type":"print"},{"value":"2050-3121","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"article-number":"20503121211032480"}}